Until · 4 months ago
Research Associate (Organ Perfusion)
San Francisco, CA
Full-time
Onsite
Entry, Mid Level
$90K/yr - $100K/yr
2+ years expUntil is a moonshot company focused on developing revolutionary organ preservation techniques. The Research Associate will play a crucial role in advancing the scientific research program, primarily developing organ perfusion protocols and collaborating with a diverse team of scientists and engineers.
BiotechnologyLife Science
Responsibilities
Perform pig organ isolation and ex-vivo evaluation protocols, including perfusion and histology
Work within scientific team to evaluate health of organs following cryopreservation
Survey literature and conduct experimental tests to answer critical questions towards optimizing preservation protocol
Ensure accurate sample processing and on-time data reporting
Qualification
Required
You have an undergraduate degree in a STEM field, or significant STEM-related training
You have 2 years experience and an excellent record of success performing complex and demanding laboratory procedures, ideally with training in ex vivo organ perfusion and viability assessment
You have demonstrated a passion for rapid problem solving and exploration of novel topics / protocols
Desire to work in a laboratory setting
You have experience or interest in physiology, with a creative approach to understanding and manipulating functions of organs
You demonstrate agency, problem solving, passion for discovery, and a drive to push the boundaries of science through meaningful involvement in an ambitious project
Benefits
Opportunity for outsized impact creating the future as an early team member
Generous medical, dental and vision insurance coverage
Flexible time off and paid holidays
Competitive compensation package, including salary and equity
401(k) retirement savings plan
FSA and commuter benefits
Subsidized lunch daily
Company
Until
We are building reversible cryopreservation technology to solve the organ procurement and matching problem.
11-50 employees
Funding
Current Stage
Early StageTotal Funding
$106MKey Investors
Founders Fund
2025-09-22Series A· $58M
2024-06-06Series A· $48M
Leadership Team
Hunter Davis
Co-founder, CSO
Recent News
2025-11-28
Company data provided by crunchbase